Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation

Haematologica 2026 Open access

Read full text
Authors: Federica Sora', Andrea Bacigalupo, Sabrina Giammarco, Elisabetta Metafuni, Filippo Frioni, Eugenio Galli, Maria Assunta Limongiello, Simona Sica, Patrizia Chiusolo
DOI: 10.3324/haematol.2025.288371
Cited by: 0

Abstract

We studied platelet recovery in 93 patients with myelofibrosis, following an allogeneic hemopoietic stem cell transplant (HSCT). The primary end point of the study was achieving a platelet count of 50x109/L within day +100 post transplant, which occurred in 62 patients (67%), predicted 5-year non-relapse mortality (NRM) (5% vs. 55%, P=0.0009) and 5-year actuarial survival (85% vs. 38%, P

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Myeloproliferative Neoplasms: Diagnosis and Treatment Platelet Disorders and Treatments

Publication details

Journal / source
Haematologica
Volume
111
Issue
6
Pages
2080–2086
Publication date
15 January 2026
Language
EN